Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
By mid-September, the Centers for Disease Control and Prevention reported the Omicron subvariant KP.3.1.1 accounted for most COVID-19 cases. KP.3.1.1 is a member of a group of variants nicknamed ...
The FDA granted emergency use authorization last week to an updated version of the Novavax shot, which includes a "monovalent ...
The new Covid variants are here, and as cold and flu season coincides with a busy travel season, here's what both Covid ...
Invivyd Inc. beat a shareholder lawsuit alleging the biopharma company misled shareholders with optimistic projections about the effectiveness of its Covid-19 treatment against the omicron variant.
The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...
Omicron has proved to be not only staggeringly infectious, but an evolutionary marvel. Read more here. Some people who experience cognitive issues after long COVID continue to struggle with brain ...
Health Canada has told the provinces to pull existing supplies of the COVID-19 vaccine that targets the XBB form of Omicron, a spokesperson for Ontario's health minister says. "Health Canada has ...